Phosphonium lipocations as antiparasitic agents.
Timothy E Long1, Xiao Lu, Melina Galizzi
1Department of Pharmaceutical and Biomedical Sciences and Center for Drug Discovery, University of Georgia, Athens, GA 30602, USA. tlong@rx.uga.edu
Bioorganic & Medicinal Chemistry Letters
|March 15, 2012
Summary
New phosphonium lipocation compounds show promise for treating malaria and Chagas disease. These compounds effectively inhibited the growth of Plasmodium falciparum and Trypanosoma cruzi in laboratory tests.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Drug Discovery
Background:
- Malaria, caused by Plasmodium falciparum, and Chagas disease, caused by Trypanosoma cruzi, remain significant global health challenges.
- Developing novel therapeutic agents is crucial for combating drug resistance and improving treatment outcomes for these parasitic diseases.
Purpose of the Study:
- To synthesize and evaluate novel phosphonium lipocations for their potential as anti-parasitic agents.
- To assess the in vitro efficacy of these compounds against Plasmodium falciparum and Trypanosoma cruzi.
Main Methods:
- Synthesis of phosphonium lipocations, including phthalimide and 1,4-naphthoquinone-based structures.
- In vitro evaluation of synthesized compounds against Plasmodium falciparum and Trypanosoma cruzi.
- Determination of inhibitory concentrations (nM and µM) for active compounds.
Main Results:
- Several phosphonium lipocations demonstrated significant in vitro activity against Plasmodium falciparum.
- Optimal phthalimide and 1,4-naphthoquinone-based lipocations were effective against T. cruzi.
- Compounds exhibited activity in the mid-high nanomolar range against P. falciparum and low micromolar range against T. cruzi.
Conclusions:
- Phosphonium lipocations represent a promising class of compounds for the development of new anti-malarial and anti-Chagas disease therapies.
- The identified active structures provide a foundation for further optimization and development of lead drug candidates.
More Related Videos
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
Related Concept Videos
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:32Membrane Lipids
Lipids are an essential component of all biological membranes. The average lipid content in mammalian membranes is 50%, though it can be as low as 20% in the inner mitochondrial membrane or as high as 80% in the myelin sheath present around the nerve cells.
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...
01:27Synthesis of Phosphatidylcholine in the ER Membrane
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...